Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026)
Ginkgo Bioworks Holdings posted quarterly Assets Average of $1.1 billion for Q1 2026, down 19.4% year-on-year from $1.3 billion in Q1 2025, and down 6.76% on a QoQ basis from $1.2 billion in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 6 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 19.4% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 19.4% YoY), and the FY2025 full-year result was $1.2 billion, down 17.93% from the prior year.
- Assets Average for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.5 billion in Q1 2023 and bottomed at $1.1 billion in Q1 2026.
- The 5-year median for Assets Average is $1.6 billion (2024), against an average of $1.7 billion.
- The widest annual swing landed in 2022, when Assets Average surged 71.8%; it then sank 34.49% in 2024.
- A 5-year view of Assets Average shows it stood at $2.2 billion in 2022, then decreased by 16.29% to $1.8 billion in 2023, then fell by 22.57% to $1.4 billion in 2024, then dropped by 19.22% to $1.2 billion in 2025, then slipped by 6.76% to $1.1 billion in 2026.
- The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.85 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 2.35 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.93 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.11 Bn |
| Sep 30, 2021 | 1.94 Bn |
| Jun 30, 2021 | 1.73 Bn |
| Mar 31, 2021 | 1.20 Bn |